GENERIC NAME: TRABECTEDIN
PROPRIETARY NAME: Yondelis (Centocor Ortho Biotech)
APPROVAL RATING: NDA Submitted
THERAPEUTIC CLASS: Antitumor Agents
SIMILAR DRUGS: None
INDICATIONS: Trabectedin has been submitted for Food and Drug Administration (FDA) approval for use in combination with doxorubicin liposome injection in the treatment of relapsed ovarian cancer.
.....